Fungal Diagnostics Leverage the FungiFlex Mold Panel launch and CLIA-certified reference laboratory to target hospitals and reference labs with rapid, noninvasive fungal diagnostics; offer CRO-supported validation and integration services to accelerate adoption.

CRO Partnerships Promote Zepto Life Technology’s CRO capabilities to pharma and biotech clients seeking to bring multiplex diagnostics to market, emphasizing assay development, validation, regulatory support, and scalable production workflows using GMR technology.

GMR Advantage Position the Giant Magnetoresistance multiplex panels as faster, more scalable alternatives to culture-based tests, highlighting breadth of pathogens, panel multiplexing, and user-friendly workflows to diagnostic labs and health systems.

Strategic Alliances Leverage the advisory board addition to engage academia and translational medicine networks for pilot studies, collaborations, and grant-funded diagnostic projects that validate and expand product reach.

Market Expansion Pursue partnerships with hospital networks, reference laboratories, and public health labs to expand geography and service bundles, offering integrated diagnostic and CRO-enabled testing programs.